Dissecting Androgen excess and metabolic dysfunction - an Integrated SYstems approach to PolyCystic Ovary Syndrome (DAISY-PCOS)

Dunn, Warwick (Co-Investigator)
Tino, Peter (Co-Investigator)
Deeks, Jon (Co-Investigator)
Arlt, Wiebke (Principal Investigator)
Manolopoulos, Konstantinos (Co-Investigator)
O'Reilly, Michael (Co-Investigator)
Afford, Simon (Co-Investigator)

Short title	Dissecting Androgen excess and metabolic dysfunction - an Integrated SYstems approach to PolyCystic Ovary Syndrome (DAISY-PCOS)
Status	Finished
Effective start/end date	1/04/18 → 1/10/24

Funding

The Wellcome Trust

11 Article
2 Review article
1 Comment/debate

Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion
Prete, A., Abdi, L., Canducci, M., van den Brandhof, E. L., Albors-Zumel, A., Jenkinson, C., Gilligan, L. C., Zhang, Y., Visser, L., Chortis, V., Najdekr, L., Jankevics, A., Lloyd, G. R., Winder, C. L., Tsagarakis, S., Lang, K., Macech, M., Fell, V., Vodanovic, I. D. & Reimondo, G. & 32 others, Marina, L. V., Deutschbein, T., Balomenaki, M., O'Reilly, M. W., Bednarczuk, T., Dusek, T., Diamantopoulos, A., Asia, M., Kondracka, A., Yu, K., Masjkur, J. R., Quinkler, M., Ueland, G. Å., Dennedy, M. C., Beuschlein, F., Tabarin, A., Fassnacht, M., Ivovic, M., Terzolo, M., Kastelan, D., Young, Jr., W. F., Manolopoulos, K. N., Ambroziak, U., Vassiliadi, D. A., Bancos, I., Sitch, A. J., Taylor, A. E., Tino, P., Biehl, M., Dunn, W. B., Arlt, W. & ENSAT EURINE-ACT Investigators, Feb 2026, In: EBioMedicine. 124, 17 p., 106126.
Research output: Contribution to journal › Article › peer-review

Open Access
File
14 Downloads (Pure)
Premature adrenarche and metabolic risk: a systematic review and meta-analysis
Ben Said, W., Lempesis, I. G., Fernandez-Garcia, S., Thangaratinam, S., Arlt, W. & Idkowiak, J., 30 Aug 2025, In: European Journal of Endocrinology . 193, 3, p. S1-S14 14 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
39 Downloads (Pure)
5α-reduction of epitestosterone is catalysed by human SRD5A1 and SRD5A2 and increases androgen receptor transactivation
Schiffer, L., Arlt, W. & Storbeck, K.-H., 1 Jul 2024, In: The Journal of Steroid Biochemistry and Molecular Biology. 241, 106516.
Research output: Contribution to journal › Article › peer-review

Open Access
File
83 Downloads (Pure)

Dissecting Androgen excess and metabolic dysfunction - an Integrated SYstems approach to PolyCystic Ovary Syndrome (DAISY-PCOS)

Project Details

Funding

Fingerprint

Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion

Premature adrenarche and metabolic risk: a systematic review and meta-analysis

5α-reduction of epitestosterone is catalysed by human SRD5A1 and SRD5A2 and increases androgen receptor transactivation

Dissecting Androgen excess and metabolic dysfunction - an Integrated SYstems approach to PolyCystic Ovary Syndrome (DAISY-PCOS)

Project Details

Funding

Fingerprint

Research output

Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion

Premature adrenarche and metabolic risk: a systematic review and meta-analysis

5α-reduction of epitestosterone is catalysed by human SRD5A1 and SRD5A2 and increases androgen receptor transactivation